Shionogi’s Mulpleta gets FDA green light for patients with liver diseaseThe US drug regulator has approved Mulpleta (lusutrombopag) as a treatment for thrombocytopenia in certain patients with chronic Share XShionogi’s Mulpleta gets FDA green light for patients with liver diseasehttps://pharmaphorum.com/news/shionogis-mulpleta-gets-fda-green-light-for-patients-with-liver-disease/
